Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Happich

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 21, 2004
Priorities and prospect theoryM Happich, B Mazurek
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|August 30, 2008
[Overall burden to society caused by hyperkinetic syndrome (HKS) and attention deficit hyperactivity disorder (ADHD)]O Schöffski, S Sohn, M Happich
Current Medical Research and Opinion|July 9, 2008
Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE studyA Liebl, L Breitscheidel, C Nicolay, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|July 21, 2005
KORA--a research platform for population based health researchR Holle, M Happich, H Löwel, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|July 21, 2005
Utilization of out- and inpatient health services by obese adults: a population-based study in the Augsburg region, GermanyT von Lengerke, M Happich, P Reitmeir, et al.
Diabetes Research and Clinical Practice|January 12, 2008
The economic burden of nephropathy in diabetic patients in Germany in 2002M Happich, R Landgraf, W Piehlmeier, et al.
Diabetes, Obesity & Metabolism|September 8, 2009
Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German settingT Mittendorf, J Smith-Palmer, L Timlin, et al.
The Journal of Prevention of Alzheimer'S Disease|February 14, 2019
Utilization of Observational Data as a Proxy Cohort for Comparison Purposes with Open-Label Study Results: An Example from Alzheimer's DiseaseC Reed, M Happich, J Raskin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
The Value of Diagnostic Tests for Alzheimer's Disease: Discrete-Choice Experiment and Contingent-ValuationA C Mühlbacher, F R Johnson, J C Yang, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|February 20, 2009
Longitudinal change in HbA1c in patients with type 2 diabetes: comparison of short-acting, biphasic and basal insulinW Rathmann, K Strassburger, K Kostev, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 21, 2004
Priorities and prospect theoryM Happich, B Mazurek
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|August 30, 2008
[Overall burden to society caused by hyperkinetic syndrome (HKS) and attention deficit hyperactivity disorder (ADHD)]O Schöffski, S Sohn, M Happich
Current Medical Research and Opinion|July 9, 2008
Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE studyA Liebl, L Breitscheidel, C Nicolay, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|July 21, 2005
KORA--a research platform for population based health researchR Holle, M Happich, H Löwel, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|July 21, 2005
Utilization of out- and inpatient health services by obese adults: a population-based study in the Augsburg region, GermanyT von Lengerke, M Happich, P Reitmeir, et al.
Diabetes Research and Clinical Practice|January 12, 2008
The economic burden of nephropathy in diabetic patients in Germany in 2002M Happich, R Landgraf, W Piehlmeier, et al.
Diabetes, Obesity & Metabolism|September 8, 2009
Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German settingT Mittendorf, J Smith-Palmer, L Timlin, et al.
The Journal of Prevention of Alzheimer'S Disease|February 14, 2019
Utilization of Observational Data as a Proxy Cohort for Comparison Purposes with Open-Label Study Results: An Example from Alzheimer's DiseaseC Reed, M Happich, J Raskin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
The Value of Diagnostic Tests for Alzheimer's Disease: Discrete-Choice Experiment and Contingent-ValuationA C Mühlbacher, F R Johnson, J C Yang, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|February 20, 2009
Longitudinal change in HbA1c in patients with type 2 diabetes: comparison of short-acting, biphasic and basal insulinW Rathmann, K Strassburger, K Kostev, et al.
Pageof 2